Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday
Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday
美光、艾瑞斯能源、Trip.com集团和其他大股周一走高
U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday.
美国股市走低,道琼斯指数周一下跌约250点。
Shares of Micron Technology, Inc. (NASDAQ:MU) rose sharply during Monday's session after B of A Securities maintained a Buy rating on the stock and raised its price target from $120 to $144.
美光科技公司(纳斯达克股票代码:MU)的股价在周一的交易中大幅上涨,此前B类A证券维持该股的买入评级并将其目标股价从120美元上调至144美元。
Micron Technology shares climbed 6.6% to $125.69 on Monday.
周一,美光科技股价上涨6.6%,至125.69美元。
Here are some other big stocks recording gains in today's session.
以下是今天交易日其他一些上涨的大型股票。
- Doma Holdings Inc. (NYSE:DOMA) shares rose 34% to $6.08 after the company entered a merger transaction with TRG to go private at $6.29 per share in cash.
- Mesoblast Limited (NASDAQ:MESO) gained 22.4% to $6.13 after the FDA earlier in the week informed the company that the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of the proposed Biologics License Application for remestemcel-L.
- SolarMax Technology, Inc. (NASDAQ:SMXT) rose 22.1% to $11.18.
- Ouster, Inc. (NYSE:OUST) shares jumped 19.8% to $9.51.
- Jiuzi Holdings, Inc. (NASDAQ:JZXN) gained 17.2% to $4.09.
- Ballard Power Systems Inc. (NASDAQ:BLDP) gained 16.4% to $3.2350 after the company announced the signing of a Long Term Supply Agreement with Solaris for the supply of 1,000 hydrogen fuel cell engines for the European transit bus market.
- Iris Energy Limited (NASDAQ:IREN) climbed 16% to $6.26. Cantor Fitzgerald analyst Josh Siegler reiterated Iris Energy with an Overweight and maintained a $10 price target.
- Allego N.V. (NASDAQ:ALLG) gained 15.2% to $1.67.
- GigaCloud Technology Inc. (NASDAQ:GCT) rose 13.3% to $30.26.
- ZimVie Inc. (NASDAQ:ZIMV) gained 12.6% to $18.56. ZimVie announced closing of sale of spine business to an affiliate of H.I.G. Capital for $375 million in total consideration.
- DouYu International Holdings Limited (NASDAQ:DOYU) gained 12% to $7.38.
- COMPASS Pathways plc (NASDAQ:CMPS) gained 10.6% to $9.20. Morgan Stanley analyst Vikram Purohit initiated coverage on Compass Pathways with an Overweight rating and announced a price target of $30.
- Coeur Mining, Inc. (NYSE:CDE) rose 9.6% to $4.1350 amid strength in precious metals stocks as gold rises on rate cut hopes.
- Trip.com Group Limited (NASDAQ:TCOM) climbed 7.6% to $47.24. Citigroup analyst Brian Gong maintained Trip.com Group with a Buy and raised the price target from $53 to $55.
- NexGen Energy Ltd. (NYSE:NXE) gained 7% to $8.31.
- Western Digital Corporation (NASDAQ:WDC) rose 5.7% to $72.13.
- The Chemours Company (NYSE:CC) gained 6.4% to $27.94. Chemours recently said it identified four material weaknesses amid its internal control over financial reporting.
- Doma Holdings Inc.(纽约证券交易所代码:DOMA)股价上涨34%,至6.08美元,此前该公司与TRG进行了合并交易,以每股6.29美元的现金进行私有化。
- Mesoblast Limited(纳斯达克股票代码:MESO)上涨22.4%,至6.13美元,此前美国食品药品管理局在本周早些时候告知该公司,其3期研究 MSB-GVHD001 的可用临床数据似乎足以支持Remestemcel-L的拟议生物制剂许可证申请的提交。
- SolarMax Technology, Inc.(纳斯达克股票代码:SMXT)上涨22.1%,至11.18美元。
- Ouster, Inc.(纽约证券交易所代码:OUST)股价上涨19.8%,至9.51美元。
- 九子控股有限公司(纳斯达克股票代码:JZXN)上涨17.2%,至4.09美元。
- 巴拉德动力系统公司(纳斯达克股票代码:BLDP)上涨16.4%,至3.2350美元,此前该公司宣布与Solaris签署长期供应协议,为欧洲公交巴士市场供应1,000台氢燃料电池发动机。
- 艾瑞斯能源有限公司(纳斯达克股票代码:IREN)上涨16%,至6.26美元。坎托·菲茨杰拉德分析师乔什·西格勒重申艾瑞斯能源增持,并维持10美元的目标股价。
- Allego N.V.(纳斯达克股票代码:ALLG)上涨15.2%,至1.67美元。
- GigaCloud Technology Inc.(纳斯达克股票代码:GCT)上涨13.3%,至30.26美元。
- ZimVie Inc.(纳斯达克股票代码:ZIMV)上涨12.6%,至18.56美元。ZimVie宣布完成向H.I.G. Capital子公司出售脊柱业务,总对价为3.75亿美元。
- 斗鱼国际控股有限公司(纳斯达克股票代码:DOYU)上涨12%,至7.38美元。
- COMPASS Pathways plc(纳斯达克股票代码:CMPS)上涨10.6%,至9.20美元。摩根士丹利分析师维克拉姆·普罗希特以增持评级启动了对Compass Pathways的报道,并宣布目标股价为30美元。
- 由于黄金因降息希望而上涨,贵金属股走强,科尔矿业公司(纽约证券交易所代码:CDE)上涨9.6%,至4.1350美元。
- 携程集团有限公司(纳斯达克股票代码:TCOM)上涨7.6%,至47.24美元。花旗集团分析师布莱恩·贡维持Trip.com集团的买入,并将目标股价从53美元上调至55美元。
- NexGen Energy Ltd.(纽约证券交易所代码:NXE)上涨7%,至8.31美元。
- 西部数据公司(纳斯达克股票代码:WDC)上涨5.7%,至72.13美元。
- 科慕公司(纽约证券交易所代码:CC)上涨6.4%,至27.94美元。Chemours最近表示,它在财务报告的内部控制中发现了四个重大缺陷。
Now Read This: Insiders Buying Outlook Therapeutics And 2 Other Stocks
现在读这个: 业内人士购买Outlook Therapeutics和其他2只